Wonderling, US
Laura Wonderling, Minneapolis, MN US
Patent application number | Description | Published |
---|---|---|
20100221253 | Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use - The present invention provides isolated polypeptides isolatable from a | 09-02-2010 |
20110206674 | Yersinia SPP. Polypeptides and Methods of Use - The present invention provides isolated polypeptides isolatable from a | 08-25-2011 |
20120003269 | Compositions Produced Using Enteric Pathogens and Methods of Use - The present invention provides compositions including polypeptides having the characteristics of polypeptides expressed by a reference microbe such | 01-05-2012 |
20120164685 | POLYPEPTIDES AND IMMUNIZING COMPOSITIONS CONTAINING GRAM POSITIVE POLYPEPTIDES AND METHODS OF USE - The present invention provides isolated polypeptides isolatable from a | 06-28-2012 |
Laura Wonderling, Des Moines, IA US
Patent application number | Description | Published |
---|---|---|
20080200650 | Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use - The present invention provides isolated polypeptides isolatable from a | 08-21-2008 |
20100111903 | COMPOSITIONS PRODUCED USING ENTERIC PATHOGENS AND METHODS OF USE - The present invention provides compositions including polypeptides having the characteristics of polypeptides expressed by a reference microbe such | 05-06-2010 |
20130280300 | Polypeptides and Immunizing Compositions Containing Gram Positive Polypeptides and Methods of Use - The present invention provides isolated polypeptides isolatable from a | 10-24-2013 |
20130287813 | Polypeptides and Immunizing Compositions Containing Gram Positive Polypeptides and Methods of Use - The present invention provides isolated polypeptides isolatable from a | 10-31-2013 |
20130288952 | Polypeptides and Immunizing Compositions Containing Gram Positive Polypeptides and Methods of Use - The present invention provides isolated polypeptides isolatable from a | 10-31-2013 |
20140005360 | Polypeptides and Immunizing Compositions Containing Gram Positive Polypeptides and Methods of Use | 01-02-2014 |
20140161834 | Yersinia spp. Polypeptides and Methods of Use - The present invention provides isolated polypeptides isolatable from a | 06-12-2014 |
20140161838 | Yersinia spp. Polypeptides and Methods of Use - The present invention provides isolated polypeptides isolatable from a | 06-12-2014 |
20140170164 | Yersinia spp. Polypeptides and Methods of Use - The present invention provides isolated polypeptides isolatable from a | 06-19-2014 |
20150023969 | POLYPEPTIDES AND IMMUNIZING COMPOSITIONS CONTAINING GRAM POSITIVE POLYPEPTIDES AND METHODS OF USE - The present invention provides isolated polypeptides isolatable from a | 01-22-2015 |
Ramani S. Wonderling, Mundelein, IL US
Patent application number | Description | Published |
---|---|---|
20090198043 | FELINE IL-18 PROTEINS - The present invention relates to canine and feline proteins. In particular, the present invention discloses feline interleukin-18, feline caspase-1, feline interleukin-12 single chain and canine interleukin-12 single chain proteins. The present invention also includes feline interleukin-18, feline caspase-1, feline interleukin-12 single chain and canine interleukin-12 single chain nucleic acid molecules encoding such proteins, antibodies raised against such proteins and/or inhibitors of such proteins or nucleic acid molecules. The present invention also includes therapeutic compositions comprising such nucleic acid molecules, proteins, antibodies and/or inhibitors, as well as their use to evaluate and regulate an immune response in an animal. | 08-06-2009 |
20100285529 | FELINE GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PROTEINS - The present invention relates to canine interleukin-4, canine or feline Flt-3 ligand, canine or feline CD40, canine or feline CD154, canine interleukin-5, canine interleukin-13, feline interferon alpha, and/or feline GM-CSF proteins; to canine interleukin-4, canine or feline Flt-3 ligand, canine or feline CD40, canine or feline CD 154, canine interleukin-5, canine interleukin-13, feline interferon alpha, and/or feline GM-CSF nucleic acid molecules, including those that encode canine interleukin-4, canine or feline Flt-3 ligand, canine or feline CD40, canine or feline CD 154, canine interleukin-5, canine interleukin-13, feline interferon alpha, and/or feline GM-CSF proteins, respectively; to antibodies raised against such proteins; and to inhibitory compounds that regulate such proteins. The present invention also includes methods to identify and obtain such proteins, nucleic acid molecules, antibodies, and inhibitory compounds. Also included in the present invention are therapeutic compositions comprising such proteins, nucleic acid molecules, antibodies and/or inhibitory compounds as well as the use of such therapeutic compositions to regulate an immune response in an animal. | 11-11-2010 |
Ramani S. Wonderling, Ivanhoe, IL US
Patent application number | Description | Published |
---|---|---|
20090305348 | DIAGNOSTIC TEST FOR VITAMIN B12 - An isolated nucleotide sequence or fragment thereof encoding the porcine intrinsic factor, wherein the porcine intrinsic factor comprises an amino acid sequence having at least 85% amino acid sequence identity to an amino acid sequence selected from the group consisting of SEQ ID NO: 3, SEQ ID NO: 6, and SEQ ID NO: 9. The invention also encompasses an isolated nucleic acid sequence or fragment thereof comprising, or complementary to, a nucleotide sequence having at least 85% nucleotide sequence identity to a nucleotide sequence selected from the group consisting of SEQ ID NO: 1, SEQ ID NO: 4, and SEQ ID NO: 7. The porcine intrinsic factor can be use is an assay to determine the quantity of vitamin B | 12-10-2009 |
20100124754 | Cloning, Expression And Purification Of Recombinant Porcine Intrinsic Factor For Use In Diagnostic Assay - The present invention relates to a new method of producing functionally active recombinant porcine Intrinsic Factor as well as the protein (i.e., porcine Intrinsic Factor) produced thereby. In particular, the vector comprising the DNA encoding the protein is introduced into a Chinese Hamster Ovary (CHO) host cell under conditions sufficient for optimal expression of functional protein. The expressed protein may then be subjected to three methods ultimately resulting in a protein having at least 97% purity. | 05-20-2010 |
Ramani S. Wonderling, Waukegan, IL US
Patent application number | Description | Published |
---|---|---|
20090060948 | CATIONIC LIPID-MEDIATED ENHANCEMENT OF NUCLEIC ACID IMMUNIZATION OF CATS - The present invention relates to a method to introduce a nucleic acid molecule into a fetid by administration of a nucleic acid-cationic lipid complex composition. The method includes the step of administering to the felid, by a parenteral route, a nucleic acid-cationic lipid complex to elicit and/or enhance an immune response. In one embodiment, this method enhances the immune response in a fetid compared to a method in which a naked DNA vaccine is administered to a felid. Also provided is a method to deliver a nucleic acid to a felid. This method comprises parenterally administering to the fetid a composition that includes a nucleic acid molecule complexed with a cationic lipid. | 03-05-2009 |